Edging closer towards the goal of a dengue vaccine
Dengue is a growing global problem that urgently needs to be addressed [1]. Similarly to yellow fever, dengue is caused by viruses of the flaviviridae family and transmitted by Aedes mosquitoes, but unlike yellow fever for which we have had a vaccine for more than 80 years, the first dengue vaccine...
Main Authors: | Wilder-Smith, Annelies, Yoon, In-Kyu |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Journal Article |
Language: | English |
Published: |
2016
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/80193 http://hdl.handle.net/10220/40434 |
Similar Items
-
Analysis of the evidence about the efficacy and safety of the CYD-TDV dengue vaccine and its potential licensing and implementation within the Mexican Universal Vaccination Program
by: Mauricio Hernández-Ávila, et al.
Published: (2016-02-01) -
The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review
by: Raksheeth Agarwal, et al.
Published: (2017-04-01) -
Analysis of the evidence on the efficacy and safety of CYD-TDV dengue vaccine and its potential licensing and implementation through Mexico´s Universal Vaccination Program
by: Mauricio Hernández-Ávila, et al.
Published: (2016-01-01) -
Safety of dengue vaccine (CYD-TDV) in Asia: a systematic review
by: W. R. Wan Ismail, et al.
Published: (2021-06-01) -
Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5–6 years after completion of the primary series
by: Juliana Park, et al.
Published: (2020-03-01)